New York, NYNCT06212193Now EnrollingIRB Ready

Tricuspid Regurgitation Clinical Trial in New York, NY

Access cutting-edge tricuspid regurgitation treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Innoventric LTD

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access tricuspid regurgitation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related tricuspid regurgitation treatment provided free

Apply for This New York Location

Check if you qualify for this tricuspid regurgitation clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Tricuspid Regurgitation Study in New York

Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).

Sponsor: Innoventric LTD

Who Can Participate

Inclusion Criteria

Patient has clinically significant TR graded as severe or greater
Peak central venous pressure of ≥ 15mmHg
Patient has NYHA functional classification of III or IV
Patient is not eligible for standard-of-care surgical or interventional therapy or has refused standard-of-care surgical and interventional therapy or has received standard-of-care TR therapy and remains symptomatic

Exclusion Criteria

Patients will be excluded from participation if ANY of the following criteria apply:
Severe RV dysfunction defined by TAPSE, RVEF, or RVFAC.
Anatomical suitability according to CT scan.
Systolic Pulmonary Artery Pressure \> 65mmHg
Moderate or more mitral valve stenosis
Greater than moderate mitral valve regurgitation or aortic valve stenosis/regurgitation
Moderate mitral valve regurgitation combined with moderate aortic valve stenosis/regurgitation
Kidney dysfunction with estimated Glomerular Filtration Rate (eGFR) \< 35 ml/min/1.73 m2 within 60 days prior to the index procedure or patient is on chronic dialysis
Liver cirrhosis or moderate or severe liver disease (Child-Turcotte-Pugh class B or C, or a score of 7 or higher)
Thrombocytopenia (Platelet count\< 80,000/mm3) or thrombocytosis (Platelet count \> 750,000/mm3) within 14 days of the index procedure
In the opinion of the Investigator or the study eligibility committee, the patient's life expectancy \< 12 months

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06212193) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Tricuspid Regurgitation Treatment Options in New York, NY

If you're searching for tricuspid regurgitation treatment options in New York, NY, this clinical trial (NCT06212193) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tricuspid regurgitation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all tricuspid regurgitation clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in New York, NY

See all interstitial cystitis clinical trials recruiting in New York — not just this study.

Browse Interstitial Cystitis Trials in New York →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY